DrugPatentWatch Database Preview
Details for Patent: 6,946,149
» See Plans and Pricing
Which drugs does patent 6,946,149 protect, and when does it expire?
Patent 6,946,149 protects SUPREP BOWEL PREP KIT and is included in one NDA.
This patent has twenty-seven patent family members in thirteen countries.
Summary for Patent: 6,946,149
| Title: | Salt solution for colon cleansing |
| Abstract: | The field of colonic diagnostic and surgical procedures is hampered by the lack of optimal means available to cleanse the colon. A compromise between convenient, distasteful, solid or low volume, hyperosmotic solutions which cause considerable fluid and electrolyte imbalances in patients and large volume, difficult to consume, iso-osmotic solutions has had to be made heretofore. This invention describes a low volume, hyper-osmotic solution consisting of sulfate salts with and with out polyethylene glycol. Unlike prior art, this composition is useful for the cleansing of the bowel and, in lower volumes, as a laxative, without producing clinically significant changes in bodily function. |
| Inventor(s): | Cleveland; Mark vB. (Duxbury, MA) |
| Assignee: | Braintree Laboratories, Inc. (Braintree, MA) |
| Application Number: | 10/135,857 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,946,149 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Use; |
Drugs Protected by US Patent 6,946,149
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Braintree Labs | SUPREP BOWEL PREP KIT | magnesium sulfate; potassium sulfate; sodium sulfate | SOLUTION;ORAL | 022372-001 | Aug 5, 2010 | AA | RX | Yes | Yes | Start Trial | Start Trial | Y | GASTROINTESTINAL LAVAGE INDICATED FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN ADULTS | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,946,149
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 457172 | Start Trial | |||
| Austria | 528011 | Start Trial | |||
| Australia | 2003231160 | Start Trial | |||
| Canada | 2484303 | Start Trial | |||
| Cyprus | 1110011 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
